Description

A systematic review of curcumin as complementary therapy for ulcerative colitis identified randomized controlled trials assessing clinical remission rates. The PRISMA-based study selection process is depicted.

Figure 1

Flowchart

Source Paper

The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials.

Nutrients (2020)

PMID: 32751776

DOI: 10.3390/nu12082296

Cite This Figure

![Figure 1: A systematic review of curcumin as complementary therapy for ulcerative colitis identified randomized controlled trials assessing clinical remission rates. The PRISMA-based study selection process is depicted.]()

> Source: Mariana Roque Coelho et al. "The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systemat." *Nutrients*, 2020. PMID: [32751776](https://pubmed.ncbi.nlm.nih.gov/32751776/)

<figure>
  <img src="" alt="A systematic review of curcumin as complementary therapy for ulcerative colitis identified randomized controlled trials assessing clinical remission rates. The PRISMA-based study selection process is depicted." />
  <figcaption>Figure 1. A systematic review of curcumin as complementary therapy for ulcerative colitis identified randomized controlled trials assessing clinical remission rates. The PRISMA-based study selection process is depicted.<br>  Source: Mariana Roque Coelho et al. "The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systemat." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751776/">32751776</a></figcaption>
</figure>

Preuves associées

Curcumin pour Ulcerative Colitis (UC)

Note B · 5 études

Curcumin pour Crohn's Disease

Note C · 3 études